Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
GRGreenLight Biosciences Holdings logo

GreenLight Biosciences Holdings (GRNA)

NASDAQ Global Market · Currency in USD
$0.30 ▼ 0.00 (-0.03%)
At close: Jul 21, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.30
Open
$0.30
Day's Range
$0.30 – $0.30
52 Week Range
$0.18 – $5.90
Volume
143,167
Avg. Volume
713,367
Market Cap
$45.43M
Beta (5Y Monthly)
1.44
PE Ratio (TTM)
--
EPS (TTM)
-$1.27
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$11.00

Profile: GreenLight Biosciences Holdings

Sector
Healthcare
Industry
Biotechnology
Full-time employees
280
CEO
Andrey Juan Zarur

GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops.

Earnings

DateEst.Actual
May 11, 2023-$0.15-$0.19Miss
Mar 28, 2023$0.25-$0.26Miss
Nov 9, 2022-$0.28-$0.27Beat
Sep 26, 2022–-$0.42
Mar 31, 2022–-$0.34
Dec 31, 2021–-$0.23

Analyst view

Consensus price target
$11.00 ▲ +3,572.8%
Range $4.00 – $18.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on GRNA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.